Protagonist Therapeutics Revenue 2015-2018 | PTGX

Current and historical revenue for Protagonist Therapeutics (PTGX) from 2015 to 2018. Revenue can be defined as the sum of all revenue fields included for a company's operating activities. Protagonist Therapeutics revenue for the twelve months ending June 30, 2018 was $0.043B. Protagonist Therapeutics revenue for the three months ending June 30, 2018 was $0.012B, representing a INF% increase from the same quarter last year.
Protagonist Therapeutics Annual Revenue
(Millions of US $)
2017 $20
2016 $0
2015 $0
2014 $0
Protagonist Therapeutics Quarterly Revenue
(Millions of US $)
Q2 2018 $12
Q1 2018 $11
Q4 2017 $11
Q3 2017 $9
Q2 2017 $0
Q1 2017 $0
Q4 2016 $0
Q3 2016 $0
Q2 2016 $0
Q1 2016 $0
Q4 2015 $0
Q3 2015 $0
Q2 2015 $0
Q4 2014 $0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.188B $0.020B
Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The Company's initial lead product candidates consists of PTG-100 and PTG-200, which have the potential to transform the existing treatment paradigm for inflammatory bowel disease, a GI disease consisting primarily of ulcerative colitis and Crohn's disease; PTG-300, an injectable hepcidin mimetic. Protagonist Therapeutics, Inc. is based in Milpitas, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $127.784B 14.67
Gilead Sciences (GILD) United States $94.529B 10.49
Biogen (BIIB) United States $69.542B 14.74
Celgene (CELG) United States $63.563B 12.69
Illumina (ILMN) United States $47.904B 60.01
Vertex Pharmaceuticals (VRTX) United States $44.999B 102.37
Regeneron Pharmaceuticals (REGN) United States $40.441B 22.74
Alexion Pharmaceuticals (ALXN) United States $25.852B 19.43
BioMarin Pharmaceutical (BMRN) United States $17.938B 0.00
Incyte (INCY) United States $14.625B 491.43
Seattle Genetics (SGEN) United States $11.852B 0.00
Alnylam Pharmaceuticals (ALNY) United States $9.521B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.457B 60.73
Sarepta Therapeutics (SRPT) United States $8.654B 0.00
Bluebird Bio (BLUE) United States $8.557B 0.00
QIAGEN (QGEN) Netherlands $8.509B 27.82
BeiGene (BGNE) Cayman Islands $8.458B 0.00
Alkermes (ALKS) Ireland $6.916B 0.00
Bio-Techne Corp (TECH) United States $6.782B 45.58
Exact Sciences (EXAS) United States $5.995B 0.00
Exelixis (EXEL) United States $5.722B 18.64
Ligand Pharmaceuticals (LGND) United States $5.233B 46.35
Galapagos (GLPG) Belgium $5.192B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.919B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.564B 0.00
Immunomedics (IMMU) United States $3.514B 0.00
Horizon Pharma Public (HZNP) Ireland $3.428B 19.41
Akcea Therapeutics (AKCA) United States $3.076B 0.00
Blueprint Medicines (BPMC) United States $3.059B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.058B 0.00
China Biologic Products (CBPO) China $3.048B 20.13
Array BioPharma (ARRY) United States $2.984B 0.00
Ascendis Pharma (ASND) Denmark $2.970B 0.00
Emergent Biosolutions (EBS) United States $2.965B 23.61
Myriad Genetics (MYGN) United States $2.952B 35.31
Medicines (MDCO) United States $2.941B 0.00
ARGENX SE-ADR (ARGX) Netherlands $2.733B 0.00
Global Blood Therapeutics (GBT) United States $2.566B 0.00
Amicus Therapeutics (FOLD) United States $2.500B 0.00
Halozyme Therapeutics (HALO) United States $2.478B 33.02
CRISPR THERAPTC (CRSP) Switzerland $2.316B 0.00
Spark Therapeutics (ONCE) United States $2.306B 0.00
MyoKardia (MYOK) United States $2.267B 0.00
Acceleron Pharma (XLRN) United States $2.226B 0.00
Repligen (RGEN) United States $2.169B 72.82
Momenta Pharmaceuticals (MNTA) United States $2.161B 0.00
Reata Pharmaceuticals (RETA) United States $2.141B 0.00
REGENXBIO (RGNX) United States $2.131B 33.48
Cambrex (CBM) United States $2.110B 16.92
AnaptysBio (ANAB) United States $2.070B 0.00
Genomic Health (GHDX) United States $1.965B 109.58
Mirati Therapeutics (MRTX) United States $1.940B 0.00
G1 THERAPEUTICS (GTHX) United States $1.918B 0.00
Clovis Oncology (CLVS) United States $1.856B 0.00
Arena Pharmaceuticals (ARNA) United States $1.764B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.715B 0.00
Rubius Therapeutics (RUBY) United States $1.647B 0.00
Aimmune Therapeutics (AIMT) United States $1.636B 0.00
ACADIA Pharmaceuticals (ACAD) United States $1.629B 0.00
Atara Biotherapeutics (ATRA) United States $1.628B 0.00
Insmed (INSM) United States $1.617B 0.00
Puma Biotechnology (PBYI) United States $1.593B 0.00
Allakos (ALLK) United States $1.575B 0.00
Sangamo Therapeutics (SGMO) United States $1.561B 0.00
Denali Therapeutics (DNLI) United States $1.492B 0.00
Myovant Sciences (MYOV) United Kingdom $1.433B 0.00
Innoviva (INVA) United States $1.425B 9.14
Lion Biotechnologies (IOVA) United States $1.424B 0.00
Editas Medicine (EDIT) United States $1.424B 0.00
Solid Biosciences (SLDB) United States $1.403B 0.00
BIOHAVEN PHARM (BHVN) United States $1.399B 0.00
IMMURON LTD (IMRN) Australia $1.379B 0.00
WAVE Life Sciences (WVE) Singapore $1.372B 0.00
UniQure (QURE) Netherlands $1.352B 0.00
Acorda Therapeutics (ACOR) United States $1.339B 27.92
Deciphera Pharmaceuticals (DCPH) United States $1.317B 0.00
Coherus BioSciences (CHRS) United States $1.289B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.269B 0.00
Audentes Therapeutics (BOLD) United States $1.233B 0.00
Intellia Therapeutics (NTLA) United States $1.204B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.188B 0.00
Cellectis (CLLS) France $1.177B 0.00
Retrophin (RTRX) United States $1.152B 0.00
Athenex (ATNX) United States $1.147B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.144B 2185.00
Zai Lab Unsponsored ADR (ZLAB) China $1.122B 0.00
Lexicon Pharmaceuticals (LXRX) United States $1.100B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.084B 0.00
DBV Technologies (DBVT) France $1.072B 0.00
Intra-Cellular Therapies (ITCI) United States $1.044B 0.00
NeoGenomics (NEO) United States $1.034B 181.00
CytomX Therapeutics (CTMX) United States $1.011B 0.00
Apellis Pharmaceuticals (APLS) United States $0.983B 0.00
Revance Therapeutics (RVNC) United States $0.968B 0.00
AVROBIO (AVRO) United States $0.957B 0.00
Amarin (AMRN) Ireland $0.865B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.833B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.798B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.794B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.793B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.790B 0.00
Dynavax Technologies (DVAX) United States $0.789B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.788B 0.00
Aptinyx (APTX) United States $0.764B 0.00
Heska (HSKA) United States $0.753B 64.78
Cara Therapeutics (CARA) United States $0.743B 0.00
Epizyme (EPZM) United States $0.733B 0.00
Geron (GERN) United States $0.720B 0.00
InflaRx (IFRX) Germany $0.706B 0.00
Kura Oncology (KURA) United States $0.701B 0.00
UNITY Biotechnology (UBX) $0.670B 0.00
ANI Pharmaceuticals (ANIP) United States $0.667B 13.21
Eidos Therapeutics (EIDX) United States $0.667B 0.00
Abeona Therapeutics (ABEO) United States $0.635B 0.00
Viking Therapeutics (VKTX) United States $0.634B 0.00
Sorrento Therapeutics (SRNE) United States $0.625B 0.00
Anika Therapeutics (ANIK) United States $0.614B 25.83
Verastem (VSTM) United States $0.609B 0.00
Fate Therapeutics (FATE) United States $0.598B 0.00
Mesoblast (MESO) Australia $0.593B 0.00
UROGEN PHARMA (URGN) Israel $0.591B 0.00
Arcus Biosciences (RCUS) United States $0.590B 0.00
Prothena (PRTA) Ireland $0.578B 0.00
AC Immune SA (ACIU) Switzerland $0.564B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.559B 0.00
Replimune (REPL) United States $0.538B 0.00
Arbutus Biopharma (ABUS) Canada $0.504B 0.00
Kindred Biosciences (KIN) United States $0.487B 0.00
Novavax (NVAX) United States $0.478B 0.00
Vericel (VCEL) United States $0.474B 0.00
Stemline Therapeutics (STML) United States $0.469B 0.00
Five Prime Therapeutics (FPRX) United States $0.469B 0.00
Magenta Therapeutics (MGTA) United States $0.455B 0.00
Aduro Biotech (ADRO) United States $0.455B 0.00
Zymeworks (ZYME) Canada $0.453B 0.00
GTx (GTXI) United States $0.441B 0.00
BeyondSpring (BYSI) United States $0.438B 0.00
ObsEva SA (OBSV) Switzerland $0.436B 0.00
Zealand Pharma (ZEAL) Denmark $0.434B 0.00
Merus (MRUS) Netherlands $0.432B 0.00
MiMedx (MDXG) United States $0.432B 18.52
Senesco Technologies (ELOX) United States $0.417B 0.00
Unum Therapeutics (UMRX) United States $0.409B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.407B 0.00
Inovio Pharmaceuticals (INO) United States $0.405B 0.00
Evelo Biosciences (EVLO) United States $0.395B 0.00
Cytokineticsorporated (CYTK) United States $0.393B 0.00
Kadmon Holdings (KDMN) United States $0.382B 0.00
Vital Therapies (VTL) United States $0.381B 0.00
MediciNova (MNOV) United States $0.381B 0.00
Scholar Rock Holding (SRRK) United States $0.379B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.369B 0.00
Sinovac Biotech (SVA) China $0.368B 0.00
Albireo Pharma (ALBO) United States $0.361B 0.00
Syros Pharmaceuticals (SYRS) United States $0.353B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.351B 0.00
RA PHARMCTL INC (RARX) United States $0.341B 0.00
PDL BioPharma (PDLI) United States $0.339B 4.76
Seres Therapeutics (MCRB) United States $0.329B 0.00
Adverum Biotechnologies (ADVM) United States $0.326B 0.00
Cellular Biomedicine (CBMG) United States $0.325B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.324B 0.00
Kezar Life Sciences (KZR) United States $0.321B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.316B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.310B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.307B 0.00
Kala Pharmaceuticals (KALA) United States $0.299B 0.00
ResTORbio (TORC) United States $0.298B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.296B 0.00
Osiris Therapeutics (OSIR) United States $0.296B 0.00
Selecta Biosciences (SELB) United States $0.284B 0.00
Mersana Therapeutics (MRSN) United States $0.282B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.278B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.277B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.275B 0.00
Celyad SA (CYAD) Belgium $0.275B 0.00
Athersys (ATHX) United States $0.269B 0.00
Constellation Pharmaceuticals (CNST) United States $0.269B 0.00
Celcuity (CELC) United States $0.265B 0.00
ADMA Biologics Inc (ADMA) United States $0.260B 0.00
ChromaDex (CDXC) United States $0.254B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.253B 0.00
MeiraGTx Holdings (MGTX) United States $0.253B 0.00
NantKwest (NK) United States $0.252B 0.00
Axovant Sciences (AXON) United Kingdom $0.250B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.244B 0.00
Strongbridge Biopharma (SBBP) United States $0.241B 0.00
Idera Pharmaceuticals (IDRA) United States $0.239B 0.00
Cohbar (CWBR) United States $0.238B 0.00
Liquidia Technologies (LQDA) United States $0.230B 0.00
Allena Pharmaceuticals (ALNA) United States $0.221B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.221B 0.00
Kamada (KMDA) Israel $0.219B 17.03
Clearside Biomedical (CLSD) United States $0.217B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.202B 0.00
Synlogic (SYBX) United States $0.195B 0.00
Spero Therapeutics (SPRO) United States $0.193B 0.00
Enzo Biochem (ENZ) United States $0.192B 0.00
Agenus (AGEN) United States $0.189B 0.00
Signal Genetics (MGEN) United States $0.185B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) $0.184B 0.00
Compugen (CGEN) Israel $0.180B 0.00
Menlo Therapeutics (MNLO) United States $0.177B 0.00
BioDelivery Sciences (BDSI) United States $0.170B 0.00
OVID THERAPEUTC (OVID) United States $0.169B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.169B 0.00
Krystal Biotech (KRYS) United States $0.168B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.168B 0.00
Mustang Bio (MBIO) United States $0.168B 0.00
MannKind (MNKD) United States $0.164B 0.00
TOCAGEN INC (TOCA) United States $0.162B 0.00
Cue Biopharma (CUE) United States $0.159B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.155B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.152B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.152B 0.00
XBiotech (XBIT) United States $0.149B 0.00
Organovo Holdings (ONVO) United States $0.143B 0.00
Pluristem Therapeutics (PSTI) Israel $0.140B 0.00
Intec Pharma (NTEC) Israel $0.133B 0.00
XOMA (XOMA) United States $0.133B 14.00
Cerecor (CERC) United States $0.132B 16.29
Vaccinex (VCNX) United States $0.132B 0.00
Motif Bio Plc (MTFB) United States $0.132B 0.00
Monster Digital (INNT) United States $0.131B 0.00
Provention Bio (PRVB) United States $0.130B 0.00
BioXcel Therapeutics (BTAI) United States $0.127B 0.00
Cocrystal Pharma (COCP) United States $0.124B 0.00
Catalyst Biosciences (CBIO) United States $0.123B 0.00
Anavex Life Sciences (AVXL) United States $0.123B 0.00
Aptevo Therapeutics (APVO) United States $0.122B 0.00
Checkpoint Therapeutics (CKPT) United States $0.122B 0.00
VBI Vaccines (VBIV) United States $0.121B 0.00
Cidara Therapeutics (CDTX) United States $0.120B 0.00
Trevena (TRVN) United States $0.119B 0.00
PSivida (EYPT) United States $0.108B 0.00
Tapimmune (TPIV) United States $0.107B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.106B 0.00
Fortress Biotech (FBIO) United States $0.104B 0.00
Aptose Biosciences (APTO) Canada $0.103B 0.00
NewLink Genetics (NLNK) United States $0.101B 0.00
ScPharmaceuticals (SCPH) United States $0.100B 0.00
Orgenesis (ORGS) United States $0.099B 0.00
Leap Therapeutics (LPTX) United States $0.099B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.095B 0.00
Alcobra (ARCT) Israel $0.088B 0.00
Ophthotech (OPHT) United States $0.087B 0.56
Proteostasis Therapeutics (PTI) United States $0.086B 0.00
Eleven Biotherapeutics (SESN) United States $0.086B 0.00
OncoSec Medical (ONCS) United States $0.080B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.078B 0.00
Histogenics (HSGX) United States $0.076B 0.00
Advaxis (ADXS) United States $0.076B 0.00
Applied Genetic Technologies (AGTC) United States $0.075B 0.00
Sophiris Bio (SPHS) United States $0.072B 0.00
Oncolytics Biotech (ONCY) Canada $0.072B 0.00
Evogene (EVGN) Israel $0.071B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.070B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.070B 0.00
Prima BioMed (IMMP) Australia $0.070B 0.00
Celldex Therapeutics (CLDX) United States $0.068B 0.00
VIVUS (VVUS) United States $0.066B 0.00
Axsome Therapeutics (AXSM) United States $0.064B 0.00
Alimera Sciences (ALIM) United States $0.062B 0.00
TRACON Pharmaceuticals (TCON) United States $0.061B 0.00
Entera Bio (ENTX) Israel $0.058B 0.00
Novelion Therapeutics (NVLN) Canada $0.057B 0.00
Oncobiologics (ONS) United States $0.056B 0.00
Neothetics (EVFM) United States $0.056B 0.00
Eyenovia (EYEN) United States $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.049B 0.00
Chiasma (CHMA) United States $0.049B 0.00
Caladrius Biosciences (CLBS) United States $0.048B 0.00
Curis (CRIS) United States $0.048B 0.00
Zosano Pharma (ZSAN) United States $0.047B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.046B 0.00
Bellerophon Therapeutics (BLPH) United States $0.046B 0.00
Celsion (CLSN) United States $0.045B 0.00
Moleculin Biotech (MBRX) United States $0.044B 0.00
Proteon Therapeutics (PRTO) United States $0.043B 0.00
GENPREX INC (GNPX) United States $0.041B 0.00
AZURRX BIOPHARM (AZRX) United States $0.039B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.037B 0.00
CytRx (CYTR) United States $0.037B 0.00
VTv Therapeutics (VTVT) United States $0.034B 0.00
VistaGen Therapeutics (VTGN) United States $0.034B 0.00
AquaBounty Technologies (AQB) United States $0.031B 0.00
AEterna Zentaris (AEZS) United States $0.030B 60.67
Benitec Biopharma (BNTC) Australia $0.030B 0.00
Aileron Therapeutics (ALRN) United States $0.029B 0.00
OvaScience (OVAS) United States $0.029B 0.00
Vical (VICL) United States $0.028B 0.00
Cellect Biotechnology (APOP) Israel $0.027B 0.00
Edge Therapeutics (EDGE) United States $0.027B 0.00
Arsanis (ASNS) United States $0.026B 0.00
Adial Pharmaceuticals (ADIL) United States $0.025B 0.00
Gemphire Therapeutics (GEMP) United States $0.024B 0.00
Soligenix (SNGX) United States $0.022B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.022B 0.00
Cleveland BioLabs (CBLI) United States $0.021B 0.00
RestorGenex (DFFN) United States $0.020B 0.00
ATyr Pharma (LIFE) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
Prana Biotechnology (PRAN) Australia $0.018B 0.00
Neuralstem (CUR) United States $0.018B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.017B 0.00
Novogen (KZIA) Australia $0.017B 0.00
Titan Pharmaceuticals (TTNP) United States $0.016B 0.00
Pulmatrix (PULM) United States $0.016B 0.00
TrovaGene (TROV) United States $0.014B 0.00
Therapix Biosciences (TRPX) Israel $0.012B 6.16
Cerulean Pharma (DARE) United States $0.012B 0.00
Alliqua BioMedical (ALQA) United States $0.012B 0.00
Flex Pharma (FLKS) United States $0.009B 0.00
MYOS RENS Technology (MYOS) United States $0.009B 0.00
ARCA Biopharma (ABIO) United States $0.008B 0.00
Tenax Therapeutics (TENX) United States $0.008B 0.00
Stellar Biotechnologies (SBOT) United States $0.007B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.007B 0.00
Galena Biopharma (SLS) United States $0.007B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00
Aytu Bioscience (AYTU) United States $0.000B 0.00